Literature DB >> 1383101

Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias".

R Invernizzi1, C Rosanda, G Basso, V Conter, A di Cataldo, S Fenu, M Forni, V Frappampina, D Granchi, F Locatelli.   

Abstract

BACKGROUND: Granular acute lymphoblastic leukemia (ALL) is a rare morphological variant of ALL, characterized by cytoplasmic azurophil granules or inclusions, positive for aspecific esterase and acid phosphatase, with heterogeneous features at the ultrastructural level.
METHODS: In an attempt to determine whether the presence of granules or inclusions marks a biologically distinct variety of ALL with peculiar clinical features, a prospective morphological review was undertaken of children entering AIEOP protocols for ALL in the period from 1985 to 1989.
RESULTS: Of 531 cases examined, 16 (3%) were found to have greater than 1% granular bone marrow blasts, with 7 cases (1.3%) having greater than 10%. The presence of granules or inclusions was associated with the immunophenotype of "common" ALL. There was no clear association with FAB type L1 or L2 nor with particular clinical or hematological findings at presentation. Complete remission was achieved in all cases; one patient died of infection in remission at 3 months and 2 patients relapsed after 12 and 32 months, respectively, while the others are still in remission after a minimum follow-up of 24 months.
CONCLUSIONS: In conclusion, granular morphology seems to have no prognostic importance in children ALL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383101

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  2 in total

1.  B lymphoblastic leukemia with granules mimicking acute myeloid leukemia.

Authors:  Joo Y Song; Elham Vali Khojeini; Denis M Dwyre; Brian A Jonas
Journal:  Int J Hematol       Date:  2015-07-18       Impact factor: 2.490

2.  Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient.

Authors:  Yu Ma; Qing Leng; Yue Zhao; Endi Wang
Journal:  Int J Hematol       Date:  2019-09-25       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.